dinogreeves
2 days ago
We have a head to toe liar on this board name is trans trade, get use to him. Heck I have more than half a dozen stocks that I am holding, as for OTC, AZR*H, TGL*O (my biggest position) ENZ*N, and TGR*P. See, Tranny, I will spit and chew you out, all day, any day, everyday.
dinogreeves
4 days ago
No one is better than anyone, everyone needs to do their own DD and if you believe you stick with it, if you don't then sell. For me, one of the most important thing that stands out is, this ticker trades squeaky clean, a good trader is able to tell the difference between a dirty ticker that trades even in huge volume, but doesn't do jack chit, imagine One Million volume what it would do to this ticker, once those trial results are wired to the market, any clinical trials and we are so due, it is going to make your head spin. Been doing this for 40 plus years and I know exactly how Biotech's work and once those trial results are in, everything else will be history. Buy the dip and hold for dear life.
dinogreeves
4 days ago
FRZO had no volume either, I watched that thing at 10 cents, when hocus pokus from BNC*M board was bid whacking it to 8 cents, 6-9 months later it hit 5 dollars. I think this one is also going to hit that number, the whole family owns this stock. Just not enough believers in IHUB, but when they release those clinical data to the market, the market will decide not the usual IHUBBERS.
dinogreeves
5 days ago
Yes Trademax, the only thing we can do at this point is to wait on news on any one of their clinical trials, then we will determine the true value of their science going forward. My take on this dip is pretty simple, this was being prepped/hyped by a couple of front loaders, suggesting that news could be out in 2 weeks and by the premise that trials would end on the 21st, they very well knew this was a low float and the company is not selling shares and they ran with it. This CEO has amassed a lot of resources and funds to carry their science forward. Without news, there were not enough bid support on this stock that is why the bleeding took place and maybe handful of traders took their losses and moved on. There is nothing like a stock with no dilution in sight, there is nothing like an OTC stock that has CEO is that is a PHD in the field of medicine, there is nothing like an OTC stock that has many partners in the research for their science. So we just wait.